“…The choice of SVR12 in the present study instead of a 24‐week interval from anti‐HCV treatment start may justify the different result and reinforce our hypothesis even though we cannot exclude that some patients could have a detectable but not quantifiable HIV‐RNA if retested. However, a higher adherence to ART during DAA treatment should be taken into account as well 20 . We are aware that only slight differences in viroimmunological parameters were reported but, on the other hand, the patients included were immunocompetent and with an ongoing antiretroviral treatment, even if with a different level of virological suppression.…”